Monalisa Chatterji

Co-Founder

Bangalore Urban, Karnataka, India17 yrs 9 mos experience

Most Likely To SwitchHighly Stable

Key Highlights

Expertise in drug discovery and development.
Led innovative projects in therapeutics and vaccines.
Strong background in immunology and biochemistry.

Stackforce AI infers this person is a Healthcare professional with extensive experience in drug discovery and development.

Contact

Skills

Core Skills

Drug DiscoveryBiotechnologyDiscoveryEarly DevelopmentProject ManagementImmunogenicityDrug DevelopmentClinical Program ManagementAnti-infective DiscoveryDiagnostic Product DevelopmentMonoclonal Antibody Development

Other Skills

Assay DevelopmentBio-analytical TechniquesBiochemistryBiologicsCell BiologyCell CultureCell EngineeringDNAELISAElectrophoresisHigh-throughput ScreeningImmunologyIn VitroIn VivoInfectious Diseases

About

Its been my privilege to experience drug discovery process from early discovery to clinical testing. In this journey, I have worked and learnt from many great colleagues! Time and again, have experienced the passion of the team moving molecules forward towards launch. My deepest interest continues to be in leading/participating/contributing to science that translates to better medicines accessible to all. At of Sekkei Bio, our mission is to develop novel differentiated medicines using our innovative technology platforms, that could impact patients' health globally.

Experience

Bill & melinda gates foundation

Senior Program Officer, Discovery & Translational Sciences

Oct 2018 – Sep 2021 · 2 yrs 11 mos · Seattle

Senior Program Office enabling discovery of novel candidate therapeutics for tuberculosis and viral infections.

DiscoveryTranslational SciencesTherapeutics

Sekkei bio private limited

Co-founder, Director

Nov 2017 – Present · 8 yrs 4 mos · India

At Sekkei Bio, we are passionate about developing medicines that address global unmet needs. We have made it our mission to create cutting-edge technologies that accelerate drugs and vaccines discovery. Our proprietary technologies - the computational platform allows us to design multi-targeted drugs or novel immunogens while the circular RNA platform is opening possibilities for the creation of next generation vaccines and biologics.

Drug DiscoveryBiotechnologyProject ManagementR&DImmunology

Kinexum services llc

Early development and pre-clinical expert

Jan 2017 – Oct 2018 · 1 yr 9 mos

Supporting clients from early discovery through non-clinical phase - providing high value strategic inputs to programs across different indications, risk identification and mitigation

Early DevelopmentPre-clinical ExpertiseStrategic Inputs

Biocon research limited

2 roles

Chief Scientific Manager/ Senior Director

Apr 2016 – Oct 2016 · 6 mos · Bangalore

R&D strategy framework, Led Project Management team supporting biologics R&D, Led novel anti-diabetic program.

R&D StrategyProject ManagementBiologics

Principal scientific manager/ Associate Director

Jul 2014 – Mar 2016 · 1 yr 8 mos · Bangalore

Re-positioning of novel therapeutic antibody, led Immunogenicity and bio-analytical team, de-risking of residual host cell protein contamination for the biosimilars portfolio

Therapeutic AntibodyImmunogenicityBio-analytical Techniques

Astrazeneca

3 roles

Team leader

Jan 2013 – May 2014 · 1 yr 4 mos · Bangalore, India

Led Biochemistry / high-throughput screening team, led multiple early and late stage programs, Candidate anti-tuberculosis molecule identified 1,4-azaindoles (TBA-7371). Patent authored, now part of TB alliance portfolio.

BiochemistryHigh-throughput ScreeningDrug Development

Senior Research Scientist & Global project manager

Promoted

Jan 2011 – Jan 2012 · 1 yr · Bangalore, India

Global Project manager for Lead optimization and Phase 2 clinical program, Led New Opportunities group, Involved in strategic initiatives with global R&D leadership team ‘AZ’s future R&D direction: 2025’ & ‘AZ rewards & recognition”

Lead OptimizationClinical Program ManagementStrategic Initiatives

Research Scientist

Jan 2010 – Jan 2011 · 1 yr · Bangalore, India

Led target biology team, Lead biologist for multiple anti-infective discovery programs, Steered strategic initiatives: ‘Differentiators for new TB drugs ’ and ‘TB portfolio prioritization'

Target BiologyAnti-infective Discovery

Reametrix

Senior Project Leader

Jan 2009 – Jan 2009 · 0 mo · Bangalore, India

Diagnostic product development, validation & quality control

Diagnostic Product DevelopmentQuality Control

Biocon

Associate Scientific Manager

Jan 2006 – Jan 2009 · 3 yrs

Monoclonal antibody for cancer therapy - Initiated biosimilar programs, today launched in multiple markets, Novel anti-CD6 antibody program, authored patent “Anti-CD6 antibodies in T-cell mediated auto-immune disorders”. Led cell engineering and cell line development team.

Monoclonal Antibody DevelopmentCell Engineering